Hyperinsulinemia, a compensatory response to peripheral insulin resistance, can lead to reduced insulin transport across the blood–brain barrier, resulting in decreased insulin availability in the brain (Vogelsang et al., 2018). The gene discussed is INS; the disease is hyperinsulinism.